Stock Quotes in this Article: ABIO, BMTI, BPAX, GERN, PATH

WINDERMERE, Fla. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

>>5 Huge Stocks Ready to Slingshot Higher

With that in mind, let's take a closer look at a five biotech stocks under $5 making large moves to the upside today.

Biosante Pharmaceuticals

Biosante Pharmaceuticals (BPAX) is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. This stock is trading up 9.8% to $1.55 in recent trading.

Today’s Range: $1.39-$1.58

52-Week Range: $1.21-$17.58

Volume: 660,000

Three-Month Average Volume: 772,327

>>5 Stocks Under $10 Set to Soar

From a technical perspective, BPAX is ripping higher here right off some near-term support at $1.35 with decent volume. This stock has been downtrending badly for the last six months, with shares falling from $4.62 to its recent low of $1.21 a share. During that move, shares of BPAX have consistently made lower highs and lower lows, which is bearish technical price action. That said, BPAX has now started to rebound off that $1.21 low, and it’s setting up to trigger a near-term breakout trade.

Traders should now look for long-biased trades in BPAX if it can manage to break out above some near-term overhead resistance levels at $1.50 to $1.62 with high volume. Look for a sustained move or close above those levels with volume that’s near or above 772,327 shares. If that breakout hits soon, then look for BPAX to re-test and possibly take out its next major overhead resistance levels at $1.96 to $2.25.

BioMimetic Therapeutics

BioMimetic Therapeutics (BMTI) is a biotechnology company. BioMimetic Therapeutics is engaged in developing and commercializing products to the healing of musculoskeletal injuries and diseases, including therapies for orthopedic, sports medicine and spine applications. This stock is trading up 8.3% to $3.77 in recent trading.

Today’s Range: $3.45-$3.78

52-Week Range: $1.87-$4.20

Volume: 178,000

Three-Month Average Volume: 219,025

>>5 Stocks With Big Insider Buying

From a technical perspective, BMTI is soaring higher here with decent volume, and this move has pushed the stock above some near-term overhead resistance levels at $3.44 to $3.68. Traders should now look to play the next major breakout for BMTI. That trade will trigger once BMTI takes out some near-term overhead resistance at $3.78 with high volume.

Traders should look for long-biased trades if BMTI can sustain a move or close above $3.78 with volume that’s near or above 219,025 shares. If that breakout triggers soon, then look for BMTI to re-test and possibly take out its next major overhead resistance level at $4.20. If that $4.20 level gets taken out with volume, then BMTI could be on its way to $5 in the near future.

Arca Biopharma

Arca Biopharma (ABIO) is a biopharmaceutical company. Arca Biopharma’s principal focus is developing genetically-targeted therapies for heart failure and other cardiovascular diseases. This stock is trading up 5.5% at 36 cents per share in recent trading.

Today’s Range: $0.32-$0.36

52-Week Range: $0.31-$2.45

Volume: 119,000

Three-Month Average Volume: 91,008

>>5 Rocket Stocks Worth Buying This Week

From a technical perspective, ABIO is ripping to the upside here right off some near-term support at 31 cents per share with above average volume. This move has also pushed ABIO above some near-term overhead resistance at 35 cents per share.

Traders should now look for long-biased trades as long as ABIO is trending above 35 cents with strong upside volume flows. I would consider any upside volume day that registers near or above 91,008 shares as bullish. If ABIO can maintain that trend, then this stock has a great chance of re-testing and possibly taking out its next major overhead resistance levels at 40 cents to 47 cents per share.

Geron

Geron (GERN) is a biopharmaceutical company developing therapies for cancer. This stock is trading up 12% at $1.93 in recent trading.

Today’s Range: $1.74-$1.93

52-Week Range: $1.25-$3.13

Volume: 1.2 million

Three-Month Average Volume: 687,805

From a technical perspective, GERN is exploding to the upside here right off its 200-day moving average of $1.69 with monster volume. This move has also started to push GERN above some major overhead resistance levels at $1.88 at $1.89.

Traders should now look for long-biased trades as long as GERN is trending above today’s low of $1.74 with strong upside volume flows. I would consider any upside volume day that registers near or above 687,805 shares as bullish. If GERN can continue to trade near or above those key resistance levels, then this stock will have a great chance of re-testing and possibly taking out its next major overhead resistance levels at $2.22 to $2.60

NuPathe

NuPathe (PATH) is a specialty pharmaceutical company focused on the development and commercialization of therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders. This stock is trading up 5.3% at $3.96 in recent trading.

Today’s Range: $3.77-$4.00

52-Week Range: $1.52-$5.10

Volume: 48,000

Three-Month Average Volume: 35,861

From a technical perspective, PATH is moving sharply to the upside here right off its 50-day moving average of $3.66 with above average volume. This move is quickly pushing PATH within range of triggering a major breakout trade. That trade will trigger once PATH takes out some near-term overhead resistance levels at $4.10 to $4.25 with high volume.

Traders should now look for long-biased trades once PATH sustains a move or close above those levels with volume that’s near or above 35,861 shares. If that breakout triggers soon, then PATH will have an excellent chance of re-testing and possibly taking out its next major overhead resistance level at $5.10.

To see more stocks that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Winderemere, Fla.


RELATED LINKS:







Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Windermere, Fla., is an independent trader who focuses on stocks, options, futures, commodities and currencies. He is also an outside contributor to Beconequity.com and maintains the website Maddmoney.net, which he sold to Blue Wave Advisors in 2008. Roberto studied International Business at The Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany.